ArticleNature communications2026

Publisher Correction: Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial.

Amanda L Huff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.